Smart Dividend Portfolio Edition #79: Steady and Stable
1
Dear Investor,
Welcome to the 79th edition of TipRanks’ Smart Dividend Portfolio & Newsletter.
1
1
Market-Moving News: Sep 22, 2025
Stocks ended the week firmly in the green, with the S&P 500 (SPX) gaining 1.22%, the Dow Jones Industrial Average (DJIA) rising 1.05%, and the Nasdaq-100 (NDX) jumping 2.22%. This was the third consecutive weekly gain for the S&P 500 and the Nasdaq-100, which were both boosted by strong tech-sector momentum, while the DJIA logged its second straight positive week.
All three major indexes hit all-time highs for the second consecutive session on Friday, propelled by the Federal Reserve’s outlook for two more rate cuts this year after its widely expected 0.25% reduction on Wednesday. While the market initially dipped after Fed Chair Powell described the move as “a risk-management cut,” the central bank’s rate projections chart, known as the “Dot Plot,” which showed that rate reductions may have been pulled forward, reignited optimism. The Fed held steady its forecast for inflation and unemployment, while raising its GDP growth forecast for this year, helping ease stagflation fears.
Investors repositioned around a more dovish monetary outlook, benefiting riskier trades such as growth stocks and small caps, as well as the broad tech sector. Tech leaders such as Apple (AAPL) , Alphabet (GOOGL) , and Tesla (TSLA) , part of the “Magnificent Seven” group, saw outsized weekly gains, helping lift the broader technology sector and contributing to overall market strength.
Sentiment was also supported by positive vibes from the ongoing U.S.-China trade discussions, with the TikTok divestiture deadline extended again and possible deal – that would have Oracle (ORCL) and other U.S. firms take control of the app – starting to coalesce. However, China appears to be using pressure on Nvidia (NVDA) as a negotiation technique, with the country’s authorities banning its AI chips. The news weighed on the AI leader’s performance midweek, but the stock rebounded later on the news of its massive Intel (INTC) investment, adding support to the chip sector.
This year’s stock behavior is defying all market convictions, from the “sell in May” to the “September blues.” With the Fed starting an easing cycle in a non-recessionary environment and the AI narrative apparently having harnessed more wind in its sails than many previously believed, we could see further stock-market gains. However, investors may be overly optimistic now, judging by soaring inflows into U.S. equities. Year-to-date, these inflows have totaled $294 billion, already marking the third-highest annual inflows on record – despite more than three months left till year-end. Given that U.S. stock valuations are already elevated across the board, this exuberance could expedite a period of consolidation or choppiness – or a stock correction – even with the overall outlook pointing towards a continued rally.
1
1

1
This Week’s Quality Dividend Stock Idea
Amdocs (DOX) is a global software and services provider specializing in communications, media, and financial technology solutions. It delivers cloud-based platforms, network automation software and provides a unified digital customer experience that help service providers streamline operations, accelerate digital transformation, and enhance customer engagement.
1
Growth Blueprint
Amdocs was founded in Israel in 1982, beginning as a billing software provider for telecommunications companies. As the industry expanded, so did Amdocs, reorganizing in 1995 into a holding company structure that supported a growing network of subsidiaries across North America, Europe, and beyond. The company went public on the NYSE in 1998 before moving to NASDAQ in 2014.
From its early billing systems, Amdocs steadily broadened into customer experience platforms, operations support software (OSS), and managed services, positioning itself as a long-term strategic partner to the world’s largest service providers. Growth came through a mix of organic investment and targeted acquisitions, with divestitures such as the 2020 sale of OpenMarket helping sharpen its focus on high-value opportunities.
Amdocs’s acquisition strategy over the past decade illustrates how the company has continuously repositioned itself to stay ahead of industry inflections. In 2015, it completed a landmark deal for Comverse BSS, expanding its telecom customer base and reinforcing leadership in business support systems. This was followed in 2016 by three digital engagement acquisitions – Vindicia, Brite:Bill, and Pontis – which enhanced recurring payments, digital bill presentation, and customer engagement capabilities. In 2018, Amdocs added Vubiquity to extend into content monetization and distribution for media clients.
The launch of 5G marked a new strategic phase. In 2020, Amdocs acquired Openet, a specialist in 5G charging, policy, and cloud technologies, placing the company at the forefront of next-generation monetization. A year later, the purchase of Sourced Group in Canada added cloud transformation expertise. Subsequent deals in 2022 – Roam Digital and DevOpsGroup – deepened digital consultancy and experience design capabilities, enabling operators to accelerate cloud adoption and modernize customer-facing services.
In 2023, Amdocs filled a strategic gap by acquiring the service assurance business of TEOCO after calling off a planned purchase of Mycom OSI. The TEOCO deal expanded Amdocs’s orchestration and network assurance capabilities, helping telecom operators improve service quality while unlocking new monetization opportunities. That same year, Amdocs also acquired ProCom Consulting to strengthen its advisory role in digital transformation. In 2024, it added Astadia to gain mainframe-to-cloud migration expertise and picked up network engineering assets from Pramira to support large-scale fiber deployments. Most recently, in 2025, the company completed the acquisition of Profinit, a Czech-based data science and intelligence firm, broadening its analytics, AI engineering, and digital studio services.
Alongside acquisitions, Amdocs has consistently invested in research and development to embed automation, artificial intelligence, and cloud-native architecture into its core platforms. These efforts support the rollout of next-generation networks and enable new service models, such as network-as-a-service. At the same time, the company has streamlined its portfolio by phasing out low-margin or non-core businesses, further concentrating resources on growth areas.
Through this disciplined mix of acquisitions, organic innovation, and portfolio optimization, Amdocs has transformed from a regional billing software vendor into a global leader in cloud-based OSS or business support software (BSS), digital engagement, service orchestration, and AI-driven solutions.
1
Cloud Catalyst
Amdocs is a mission-critical technology partner to communications, media, and entertainment providers, generating revenue from proprietary software platforms and long-term services contracts that support modernization and large-scale digital transformation. The company generates revenue from a mix of proprietary software platforms and long-term services engagements, helping operators modernize their operations, monetize services, and accelerate large-scale digital transformations. Its portfolio spans key technology domains – monetization, commerce and care, and service and network automation – designed to support the shift toward cloud-based, data-driven, and AI-enabled operations.
At the core of its portfolio is the CES24 suite, a telco-native, GenAI-led customer experience platform that integrates BSS, OSS, and network orchestration. Flagship products include the Amdocs Monetization Suite for billing and charging across 5G and digital services, the Amdocs Intelligent Networking Suite for end-to-end network automation, and the Customer Engagement Platform for omni-channel digital interactions. These modular, microservices-based products are deployed at scale and continuously updated under long-term contracts, driving recurring software and support revenues.
Complementing its software, Amdocs provides a full range of services, including consulting, systems integration, cloud migration, data intelligence, network engineering, and quality assurance. A major part of its business comes from managed services, where it operates and modernizes customers’ IT and network stacks under long-term agreements. These “managed transformations” typically involve migrating legacy systems to the cloud, embedding automation and AI, and running the updated systems on behalf of clients. With renewal rates consistently near 100%, managed services underpin predictable revenues and deepen customer relationships.
Amdocs is also building momentum in cloud-based modernization and software-as-a-service (SaaS) offerings. Notable projects include cloud-based modernization projects for operators such as Elisa in Finland, Claro Brazil, and a major Eastern European operator, while expanding SaaS offerings like ConnectX, marketONE, and eSIM, which now serve over 40 customers worldwide. Most clients are still early in their cloud migrations, giving Amdocs a long runway for expansion.
GenAI and data services are emerging as a new pillar for growth. While direct GenAI revenues are still modest, the larger near-term driver comes from “data plumbing”– the structuring and preparation of customer data that underpins AI deployments. These “data plumbing” services are generating meaningful revenue today and set the stage for AI-driven growth later. A good example is Amdocs’s work with E&, a company in the UAE. The company started with limited AI pilots but has been expanding them each quarter into new areas such as customer care, billing, and commerce. This shows how customers often begin small, test the technology, and then broaden usage once they see tangible benefits. Importantly, Amdocs has already converted several generative AI proofs of concept into full commercial contracts, and management expects more of these conversions ahead.
The company’s other projects include an AI-powered MVNE (Mobile Virtual Network Enabler) transition for Consumer Cellular, and joint acceleration initiatives with NVIDIA and Microsoft.
The company’s pipeline spans a mix of strategic but smaller deals, such as its digitization work with Telstra, and larger-scale engagements like a multi-year modernization and managed services expansion with a major U.S. operator. By embedding its platforms deeply into mission-critical operations, Amdocs creates high switching costs and reinforces its role as a trusted long-term partner.
This combination of recurring software revenues, resilient managed services, and innovation-led growth in cloud and AI has built a scalable business model aligned with industry shifts such as 5G rollouts, cloud adoption, and digital service transformation.
1
Earnings Momentum
Over the past five years, Amdocs has grown revenues at a CAGR of 2.3% and diluted EPS at 6.4%, supported by steady managed services expansion, cloud and AI-driven projects, operational efficiencies, and a growing contract backlog.
In the fiscal third quarter of 2025, Amdocs reported revenue of about $1.14 billion, up 3.5% year-over-year on a constant-currency basis and above consensus estimates. The company’s 12-month backlog reached $4.15 billion, a 3% increase from last year and covering roughly 90% of projected revenue. This visibility reflects both strong managed services renewals and a steady pace of new wins.
Managed services remained the backbone, accounting for 67% of total revenue. This segment generated $771 million in Q3, up 4.1% year-over-year. Its long-term contracts provide predictable revenue and help stabilize margins by reducing reliance on project timing.
Regional performance highlighted varied dynamics. North America, which remains the company’s largest market, grew modestly by 1% on a sequential basis, supported by continued demand for managed services and ongoing digital transformation projects, particularly among large U.S. service providers. Europe delivered a record quarter of revenue growth of nearly 8% year-over-year, fueled by new multi-year deals and the successful integration of Profinit, an acquisition that enhanced analytics and software engineering capabilities. In contrast, the Rest of the World showed mixed results, with strength in Latin America and Asia-Pacific offset by slower project rollouts elsewhere.
Profitability strengthened as adjusted operating margin expanded 280 basis points to 21.4%, reflecting the phaseout of non-core activities and efficiency gains. Adjusted diluted EPS came in at $1.72, slightly above both its guidance and Street expectations.
Amdocs ended the fiscal third quarter with a liquidity position of about $842 million. This included access to a $500 million revolving credit facility, which remains fully available and provides additional financial flexibility. On the debt side, the company’s long-term obligations consist primarily of a $650 million senior note, resulting in a modest debt-to-equity ratio of 0.24. This debt-to-equity ratio reflects its stable, cash-generative business model, its unique position between software and IT services, and prudent but strategic use of leverage for shareholder value. Credit rating agencies like Moody’s and S&P have assigned investment-grade credit ratings of “Baa1” and “BBB,” respectively, underscoring the company’s stable financial profile and ability to meet its obligations.
Cash generation was robust, with operating cash flow of about $241 million in Q3, up by 26% year-over-year, and free cash flow was approximately $212 million. For FY25, Amdocs reaffirmed its annual free cash flow target of $710 million-$730 million, before restructuring-related payments. This outlook implies a free cash flow conversion rate of more than 90% relative to its expected adjusted net income, reflecting the company’s strong cash generation and disciplined capital management. At current market capitalization levels, the guidance equates to a free cash flow yield of over 7%, positioning Amdocs among the top 20% of companies in the software industry. The company expects to return most of this to shareholders through dividends and buybacks while continuing to invest in cloud, GenAI, and data services.
Looking ahead, the company reaffirmed its FY2025 outlook for 2.4%–3.4% constant-currency revenue growth and double-digit cloud growth. Margins are expected to expand by 60–70 basis points this year, driven by automation and GenAI productivity gains, while adjusted diluted EPS is projected to rise 8%–9%. For Q4, revenue is forecast at $1.14 billion at midpoint, slightly below consensus, while adjusted EPS is expected at $1.82, in line with estimates.
1
Dividend Edge
Amdocs has steadily built a reputation for delivering shareholder returns through a balanced capital allocation strategy that combines regular dividends with opportunistic share repurchases. The company has consistently paid dividends and increased them over the past 13 years, reflecting its strong free cash flow generation and disciplined approach to capital management. In 2025, Amdocs paid a quarterly dividend of $0.53 per share, or $2.10 on an annualized basis, which equates to a dividend yield of 2.39% – notably high compared to the technology sector average of 0.57%. Amdocs maintains a conservative payout ratio of around 30%, which leaves room for reinvestment and buybacks.
Alongside dividends, the company regularly repurchases its shares to enhance shareholder value. In the third quarter of fiscal 2025 alone, Amdocs repurchased approximately $135 million worth of stock. As of June 30, 2025, Amdocs had around $1.12 billion remaining under its share repurchase authorizations, including a new $1 billion buyback program approved by its Board in the prior quarter.
Despite its solid operational performance, Amdocs’s stock has traded relatively flat over the past year, underperforming broader technology indices. Shares have moved within a narrow band, as investors weigh its steady execution and resilient backlog against a backdrop of cautious telecom sector spending and macroeconomic uncertainty.
Amdocs’ valuation remains attractive relative to both its own history and the broader sector. The stock is trading at levels below historical averages and significantly discounted to peer benchmarks, suggesting a gap between the company’s consistent fundamentals and prevailing market sentiment. On a non-GAAP trailing and forward P/E basis, DOX trades at more than a 50% discount to the sector median and over 15% below its historical averages. Valuations are also favorable when measured on a forward EV/EBITDA and price-to-cash flow basis, where the stock sits at more than a 40% discount to sector medians and more than a 10% discount to historical levels.
Compared to peers such as Oracle, Ericsson, and CSG International, Amdocs remains positioned at the low-to-moderate end of valuation ranges based on non-GAAP trailing and forward P/E ratios, forward EV/EBITDA, and trailing price-to-cash flow ratios, reinforcing the perception that its shares are undervalued relative to both its fundamentals and competitors.
Wall Street analysts remain optimistic about Amdocs, forecasting an average expected upside of about 26%, with the most bullish projections suggesting gains of up to 33%. Analysts highlight that margin expansion from automation and broader adoption of GenAI, alongside anticipated double-digit cloud revenue growth, should fuel steady earnings and free cash flow growth.
Supporting this perspective, a Discounted Cash Flow analysis indicates that DOX is currently trading at roughly a 35% discount to its estimated fair value.1
1
Investing Takeaway
For dividend-focused investors, Amdocs offers a compelling mix of stability, growth, and value. The company has established a long track record of steady dividend payments and increases, supported by strong free cash flow and a disciplined payout strategy. Its dividends are complemented by opportunistic share buybacks, providing an additional layer of shareholder returns. Unlike many technology peers with minimal or no yields, Amdocs stands out by offering income alongside exposure to long-term growth drivers such as cloud migration, artificial intelligence, and 5G adoption. The company’s resilient managed services base ensures predictable cash flows, while its conservative balance sheet and investment-grade ratings reinforce financial security. Trading at a discount to both historical averages and sector peers, Amdocs provides an attractive entry point for income investors seeking dependable payouts along with upside potential from continued earnings and cash flow growth.
1
Dividend Investor Portfolio
1
Portfolio News
▣ BlackRock (BLK), through its subsidiary Global Infrastructure Partners, is leading a group of investors negotiating a $10.3 billion financing deal with Saudi Aramco, according to Reuters. The agreement would provide funding to the state-owned oil producer and highlights BlackRock’s push to expand its global infrastructure and energy footprint. While not immediately material to earnings, the deal underscores BLK’s role in large-scale international financing. JPMorgan is reportedly also seeking involvement in the deal, highlighting the region’s growing attractiveness for U.S. financial giants.
▣ JPMorgan Chase (JPM) declared a quarterly dividend of $1.50 per share, an increase from a quarterly dividend of $1.40 per share in the prior year. The dividend is payable on October 31 to stockholders of record at the close of business on October 6, 2025.
▣ Philip Morris (PM) increased its regular quarterly dividend by 8.9%, moving to an annualized rate of $5.88 per share from the previous level. Shareholders will now receive a quarterly payout of $1.47 per share, up from $1.35. The dividend is scheduled to be paid on October 20 to shareholders of record at the close of business on October 3.
1
Recent Trades
None at the moment, although we are considering adding a stock to our portfolio when the market conditions allow for an attractive entry point. Stay tuned.
1
1
Portfolio Attributes
| Dividend Portfolio Yield |
Expected Dividend Growth | Expected Annual Income |
| 3.96% | +6.01% | $5,876.30 |
| Yield-on-Cost Adjusted, Weighted |
Average Analyst 12-Month Growth Outlook | 10K Per Stock at the Time of Purchase |
Current Portfolio
| Name | EX-Dividend Date | Payment Date | Yield on Cost | Annual DPS |
| Automatic Data Processing (ADP) | Dec 11, 2025 | Jan 01, 2026 | 2.46% | $6.16 |
| Amgen (AMGN) | Nov 18, 2025 | Dec 09, 2025 | 3.27% | $9.52 |
| BlackRock (BLK) | Dec 04, 2025 | Dec 23, 2025 | 2.61% | $20.84 |
| Bank of Nova Scotia (BNS) | Oct 02, 2025 | Oct 29, 2025 | 5.98% | $3.21 |
| EOG Resources (EOG) | Oct 17, 2025 | Oct 31, 2025 | 3.06% | $4.08 |
| ExxonMobil (XOM) | Nov 17, 2025 | Dec 10, 2025 | 3.64% | $3.96 |
| IBM (IBM) | Nov 12, 2025 | Dec 10, 2025 | 3.14% | $6.72 |
| JPMorgan Chase (JPM) | Oct 06, 2025 | Oct 31, 2025 | 3.43% | $6.00 |
| Kroger (KR) | Nov 17, 2025 | Dec 01, 2025 | 3.08% | $1.40 |
| Lockheed Martin (LMT) | Dec 02, 2025 | Dec 29, 2025 | 2.85% | $13.20 |
| PepsiCo (PEP) | Dec 09, 2025 | Jan 06, 2026 | 3.8% | $5.69 |
| Philip Morris (PM) | Oct 03, 2025 | Oct 20, 2025 | 6.06% | $5.88 |
| Qualcomm (QCOM) | Dec 08, 2025 | Dec 22, 2025 | 2.36% | $3.56 |
| VICI Properties (VICI) | Dec 17, 2025 | Jan 09, 2026 | 5.22% | $1.8 |
| Verizon (VZ) | Oct 09, 2025 | Nov 04, 2025 | 6.09% | $2.76 |
NameEX-Dividend DatePayment DateYield on Cost Annual DPS
1
1
1
Click here for more stock market analysis from TipRanks Macro & Markets research analyst Yulia Vaiman
1
Disclaimer
The information contained in this article represents the views and opinions of the writer only, and not the views or opinions of TipRanks or its affiliates and should be considered for informational purposes only. TipRanks makes no warranties about the completeness, accuracy, or reliability of such information. Nothing in this article should be taken as a recommendation or solicitation to purchase or sell securities. Nothing in the article constitutes legal, professional, investment, and/or financial advice and/or takes into account the specific needs and/or requirements of an individual, nor does any information in the article constitute a comprehensive or complete statement of the matters or subject discussed therein. TipRanks and its affiliates disclaim all liability or responsibility with respect to the content of the article, and any action taken upon the information in the article is at your own and sole risk. The link to this article does not constitute an endorsement or recommendation by TipRanks or its affiliates. Past performance is not indicative of future results, prices, or performance.